6-keto-prostaglandin F1α (6kPGF
1α), thromboxane B
2 (TXB
2), prostaglandin E
2 (PGE
2), prostaglandin A
1 (PGA
1), 8-iso prostaglandin A
2 (8-iso PGA
2), prostaglandin E
3 (PGE
3), 15-deoxy-Δ
12,14-prostaglandin J
2 (15d-PGJ
2), lipoxin A
4 (LxA
4), lipoxin B
4 (LxB
4), lipoxin A4 deuterated (LxA4-d5), resolvin D1 (RvD1), resolvin D2 (RvD2), 7-maresin (7-MaR1), leukotriene B
4 (LTB
4), leukotriene B
5 (LTB
5), leukotriene B
4 deuterated (LTB
4-d4), 10(S),17(S)-protectin (PDx),
18-hydroxyeicosapentaenoic acid (18-HEPE), dihydroxy-eicosatetraenoic acid (5,6-DiHETE),
15-hydroxyeicosatetraenoic acid (15-HETE) and
12-HETE,
8-HETE,
5-HETE,
5-HETE-d8, 17-hydroxy-docosahexaenoic acid (17-HDoHE) and 14-HDoHE, 14,15-epoxyeicosatrienoic acid (14,15-EET) and
11,12-EET,
8,9-EET,
5,6- EET, 5-oxoeicosatetraenoic acid (5-oxoETE) were purchased from Cayman Chemicals.
Bautzova T., Hockley J.R., Perez-Berezo T., Pujo J., Tranter M.M., Desormeaux C., Barbaro M.R., Basso L., Faouder P.L., Rolland C., Malapert P., Moqrich A., Eutamene H., Denadai-Souza A., Vergnolle N., Smith E.S., Hughes D.I., Barbara G., Dietrich G., Bulmer D.C, & Cenac N. (2018). 5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D. Science signaling, 11(561), eaal2171.